Stroke RSS Page 16

Filtered By:
Source: Heart Rhythm
Condition: Atrial Fibrillation

This page shows you your search results in order of date. This is page number 16.

Order by Relevance | Date

Total 356 results found since Jan 2013.

Silent cerebral embolism in cryoballoon ablation of atrial fibrillation: When details matter
Although the clinically manifest stroke rate related to pulmonary vein isolation (PVI) is rare and currently
Source: Heart Rhythm - July 23, 2018 Category: Cardiology Authors: Jacopo Marazzato, Roberto De Ponti Tags: Editorial Commentary Source Type: research

Silent cerebral embolism in cryoballoon ablation of atrial fibrillation: when details matter.
Although the clinically manifest stroke rate related to pulmonary vein isolation (PVI) is rare and currently
Source: Heart Rhythm - July 23, 2018 Category: Cardiology Authors: Jacopo Marazzato, Roberto De Ponti Source Type: research

Device-Guided Anticoagulation in Atrial Fibrillation: Not yet ready for prime time
Atrial fibrillation (AF), the most common sustained arrhythmia encountered in clinical practice, is associated with a three- to five-fold increased risk of stroke (accounting for>20% of all strokes).1 Independent of age and other risk factors, AF-associated strokes are relatively more severe, causing greater resource utilization, long-term disability, and mortality compared to non-AF stroke. Oral anticoagulants (OACs) are paramount in preventing AF-associated stroke and systemic thromboembolism.
Source: Heart Rhythm - July 10, 2018 Category: Cardiology Authors: Christopher C. Cheung, Jason G. Andrade Source Type: research

Screening for Atrial Fibrillation using Smartphone-based Technology and Layperson Volunteers: High-Tech Meets Community Participatory Research for the Best of Both Worlds
Atrial fibrillation (AF), usually asymptomatic and not previously-diagnosed, increases risk of stroke by five times1 and accounts for 15-25% of strokes. 2 Asymptomatic AF is estimated to affect 600,000 Americans, with an estimated cost of 3 billion dollars per year.3 Just because we can identify a risk factor does not mean screening for it will save lives. AF, however, meets most criteria laid out in the World Health Organization ’s manifesto on screening, “Principles and Practice of Screening for Disease”.
Source: Heart Rhythm - July 4, 2018 Category: Cardiology Authors: Rachel Lampert Source Type: research

Seasonal variation in the risk of ischemic stroke in patients with atrial fibrillation: A nationwide cohort study
Several cardiovascular diseases exhibit seasonal variations, but data about cold temperature and risk of ischemic stroke in patients with atrial fibrillation (AF) are limited.
Source: Heart Rhythm - July 2, 2018 Category: Cardiology Authors: Jo-Nan Liao, Tze-Fan Chao, Chia-Jen Liu, Su-Jung Chen, Chung-Lieh Hung, Yenn-Jiang Lin, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Ta-Chuan Tuan, Fa-Po Chung, Tzeng-Ji Chen, Gregory Y.H. Lip, Shih-Ann Chen Source Type: research

EP News: Allied Professionals
Using data from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) trial, Lopes et al (J Am Coll Cardiol 2018;71:1063, PMID 29519345) sought to determine the effect of digoxin on mortality in patients with atrial fibrillation (AF). ARISTOTLE is a pivotal trial involving ∼18,000 patients with AF and at least 1 risk factor for stroke with randomization to apixaban or warfarin. T he present study is a post hoc analysis of those patients who were on digoxin at baseline as compared with those not on digoxin as well as an analysis of patients taking digoxin during the cour...
Source: Heart Rhythm - April 27, 2018 Category: Cardiology Authors: Erica S. Zado Source Type: research

Is A Little Atrial Fibrillation Still Too Much?
Atrial fibrillation (AF) is most often viewed as a dichotomous variable, one that is either entirely present or absent. Guidelines support this perspective by recommending anticoagulation based on underlying stroke risk without regard to AF “type”, duration, or burden.1 The use of cardiac monitoring, however, has allowed us to quantify AF and associate outcomes with various arrhythmia characteristics.2, 3 These types of studies have raised legitimate doubts as to whether the 30 second threshold used to define AF is associated with meaningful consequences and have created equipoise for sub-clinical AF episodes lasting minutes to hours.
Source: Heart Rhythm - February 24, 2018 Category: Cardiology Authors: Rod Passman Source Type: research

Is a little atrial fibrillation still too much?
Atrial fibrillation (AF) is most often viewed as a dichotomous variable, one that is either entirely present or absent. Guidelines support this perspective by recommending anticoagulation based on underlying stroke risk without regard to AF “type,” duration, or burden.1 The use of cardiac monitoring, however, has allowed us to quantify AF and associate outcomes with various arrhythmia characteristics.2,3 These types of studies have raised legitimate doubts as to whether the 30-second threshold used to define AF is associated with m eaningful consequences and have created equipoise for subclinical AF episodes lasting minutes to hours.
Source: Heart Rhythm - February 24, 2018 Category: Cardiology Authors: Rod Passman Tags: Editorial Commentary Source Type: research

Does the CHA2DS2-VASc score reliably predict atrial arrhythmias? Analysis of a nationwide database of remote monitoring data transmitted daily from cardiac implantable electronic devices
CHA2DS2-VASc is a validated score for predicting stroke in patients with atrial fibrillation (AF).
Source: Heart Rhythm - February 22, 2018 Category: Cardiology Authors: Giovanni Rovaris, Francesco Solimene, Antonio D'Onofrio, Gabriele Zanotto, Renato P. Ricci, Tiziana Mazzella, Saverio Iacopino, Paolo Della Bella, Giampiero Maglia, Gaetano Senatore, Fabio Quartieri, Mauro Biffi, Antonio Curnis, Valeria Calvi, Antonio Rap Source Type: research

Does CHA2DS2-VASc Score reliably predict atrial arrhythmias? Analysis of a nationwide database of Remote Monitoring data daily transmitted from Cardiac Implantable Electronic Devices
CHA2DS2-VASc is a validated score for predicting stroke in patients with atrial fibrillation (AF).
Source: Heart Rhythm - February 22, 2018 Category: Cardiology Authors: Giovanni Rovaris, Francesco Solimene, Antonio D ’Onofrio, Gabriele Zanotto, Renato P. Ricci, Tiziana Mazzella, Saverio Iacopino, Paolo Della Bella, Giampiero Maglia, Gaetano Senatore, Fabio Quartieri, Mauro Biffi, Antonio Curnis, Valeria Calvi, Antonio Source Type: research

Mining the electronic medical record in patients with atrial fibrillation
I found several interesting nuggets of information in the new atrial fibrillation (AF) and stroke analysis from Patel et al1 published in this issue of HeartRhythm, starting with their use of the electronic medical record (EMR) to ask clinical questions. Most of us have a love-hate relationship with our EMR, but the undeniable truth is that it is here to stay. As you invest another late evening or the weekend catchi ng up with your EMR, how often have you wondered whether you can put all this documentation to scientific use? Certainly this is a laudable goal, but, in real life, easier said than done.
Source: Heart Rhythm - February 19, 2018 Category: Cardiology Authors: Sumeet S. Chugh Tags: Editorial Commentary Source Type: research

Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study
Stroke may be the initial manifestation of atrial fibrillation (AF). Limited studies, however, have evaluated racial differences in stroke before the diagnosis of AF.
Source: Heart Rhythm - February 19, 2018 Category: Cardiology Authors: Parin J. Patel, Ronit Katz, Yuliya Borovskiy, Anthony Killian, Joshua M. Levine, Nelson W. McNaughton, David Callans, Gregory Supple, Sanjay Dixit, Andrew E. Epstein, Francis E. Marchlinski, Rajat Deo Tags: Clinical Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20